Rivaroxaban (Xarelto®)

NICE TA 287. Guidance in development. Rivaroxaban is green for the initial dose for this indication in line with the primary care DVT pathway.

  • Traffic Light
    Amber (G)
  • BNF
    2.8.2
  • Licensed Indicators
    Treatment of PE and preventing DVT and PE in adults.
  • Reference
    APC Aug 12,Nov 12, July 13 and June 14
  • Criteria
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?